Results 111 to 120 of about 19,560 (233)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma

Indian Journal of Ophthalmology, 2011
Circumscribed choroidal hemangiomas are rare ophthalmic entities that cause diminution in vision due to accumulation of subretinal and/or intraretinal fluid in the macular area. Various treatment options ranging from conventional laser to photodynamic therapy have been employed to destroy the tumor and reduce the exudation; however, either the ...
Subrata Mandal, Prashant Naithani, Pradeep Venkatesh, SatPal Garg   +3 more
openaire   +3 more sources

Active surveillance of choroidal neovascularisation in children: incidence, aetiology and management findings from a national study in the UK [PDF]

, 2018
BACKGROUND/AIMS: To determine the UK incidence, demographics, aetiology, management and visual outcome for children developing choroidal neovascularisation (CNV).
Abbouda, A, Acheson, J, Bunce, C, Foot, B, Moore, AT, Moosajee, M   +5 more
core  

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion [PDF]

, 2011
To evaluate intravitreal bevacizumab (IVB) combined with grid laser photocoagulation in macular edema (ME) secondary to branch retinal vein occlusion (BRVO). METHODS: Eight eyes (8 patients) with ME associated with BRVO with at least
Barrio-Barrio, J. (Jesús), Caire-Gonzalez-Jauregui, J.M. (José M.), Garcia-Layana, A. (Alfredo), Sadaba-Echarri, L.M. (Luis M.), Salinas-Alaman, A. (Ángel), Zarranz-Ventura, J. (Javier)   +5 more
core  

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization [PDF]

, 2018
Background: Macular choroidal neovascularization (CNV) is one of the most vision-threatening complications of myopia, which can lead to severe vision loss.
Ambresin, Aude, Konstantinidis, Lazaros, Mantel, Irmela, Pournaras, Jean-Antoine, Zografos, Leonidas   +4 more
core  

Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizumab in Ocular Complications of Intravitreal Bevacizuma

Journal of Rawalpindi Medical College, 2016
Background: To study the rate of different complications of intravitreal Bevacizumab while treating patients of different posterior segment diseases. Methods: A prospective study of 60 patients having different retinal diseases like diabetic retinopathy, wet age related macular degeneration (AMD), retinal vein occlusion (RVO),was carried out.
openaire   +1 more source

Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up

Therapeutics and Clinical Risk Management, 2010
Eleni Loukianou, Dimitrios Brouzas, Eleni Georgopoulou, Chrysanthi Koutsandrea, Michael ApostolopoulosEye Department, University of Athens, Athens, GreecePurpose: To evaluate the safety and efficacy of intravitreal injections of bevacizumab (Avastin& ...
Eleni Loukianou, Dimitrios Brouzas, Eleni Georgopoulou, et al   +3 more
doaj  

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05

, 2016
Background: To investigate intravitreal treatment efficiencies in patients suffering from exudative ARMD with a BCVA ≤ 0.05. Methods: Retrospective analysis: Analysis parameters were lesion type, BCVA at baseline and at follow-up, the intravitreal drug ...
Busse, H. (Holger), Gebauer, S.M.I. (Sabine), Koch, R. (Raphael), Schmidt, M. (Matthias), Uhlig, C. (Constantin)   +4 more
core   +1 more source

Aflibercept monotherapy or bevacizumab first for diabetic macular edema

Indian Journal of Ophthalmology
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD).
Avner Hostovsky, Iris Moroz, Gabriel Katz   +2 more
doaj   +1 more source

Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane

Indian Journal of Ophthalmology, 2009
Choroidal neovascular membrane (CNVM) is one of the most common causes of submacular hemorrhage (SMH). Conventional treatment involves management of the SMH with pneumatic displacement with or without tissue plasminogen activator (TPA) followed by ...
Chawla Shobhit, Misra Vishal, Khemchandani Mohit   +2 more
doaj  

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration

Journal of Ophthalmic & Vision Research, 2010
Purpose: To evaluate the results of intravitreal expansile gas injection, with or without recombinant tissue plasminogen activator (rtPA), followed by intravitreal bevacizumab injection for treatment of submacular hemorrhage (SMH) secondary to ...
Ramin Nourinia, Mohammad Bonyadi, Hamid Ahmadieh   +2 more
doaj